<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21100" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Endometrial Ablation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Minalt</surname>
            <given-names>Nicole</given-names>
          </name>
          <aff>Indiana University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Canela</surname>
            <given-names>Christinne D.</given-names>
          </name>
          <aff>Virginia Tech-Carilion Clinic</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Marino</surname>
            <given-names>Sarah</given-names>
          </name>
          <aff>Michigan State University, McLaren Greater Lansing Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nicole Minalt declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christinne Canela declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarah Marino declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21100.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Endometrial ablation is a minimally invasive gynecologic surgical procedure designed to alleviate abnormal uterine bleeding in&#x000a0;patients who have met their desired parity. Abnormal uterine bleeding is defined as heavy, irregular, or intermenstrual bleeding. This ablation procedure is designed to destroy the endometrial lining of the uterine cavity. Hysterectomy has historically been considered the definitive surgical treatment for heavy menstrual bleeding. However, endometrial ablation offers several advantages, including the ability to be performed quickly as an outpatient procedure, relatively minimal pain, and a short recovery time. Endometrial ablation may be an option for patients who do not want to undergo a major surgical procedure. Several first- and second-generation ablation methods are available.&#x000a0;</p>
        <p>This activity reviews the indications, contraindications, and complications of endometrial ablation, highlighting the importance of implementing an appropriate interprofessional management approach to improve patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify appropriate candidates for endometrial ablation based on clinical guidelines and patient-specific factors.</p></list-item><list-item><p>Select appropriate ablation techniques and technologies based on individual patient needs and procedural considerations.</p></list-item><list-item><p>Screen for contraindications and potential complications associated with endometrial ablation to ensure patient safety.</p></list-item><list-item><p>Implement interprofessional team strategies to improve care coordination and outcomes&#x000a0;for patients who undergo endometrial ablation.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21100&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21100">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21100.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Endometrial ablation is a minimally invasive gynecologic surgical procedure designed to alleviate abnormal uterine bleeding in&#x000a0;patients who&#x000a0;have met their desired parity. Abnormal uterine bleeding is defined as heavy, irregular, or intermenstrual bleeding. Abnormal uterine bleeding is a common gynecologic complaint affecting 10% to 30% of reproductive-age women.<xref ref-type="bibr" rid="article-21100.r1">[1]</xref><xref ref-type="bibr" rid="article-21100.r2">[2]</xref><xref ref-type="bibr" rid="article-21100.r3">[3]</xref>&#x000a0;The ablation procedure is designed to destroy the functional layer of the endometrium to prevent its regrowth and decrease the amount of blood loss during menstruation.<xref ref-type="bibr" rid="article-21100.r4">[4]</xref><xref ref-type="bibr" rid="article-21100.r2">[2]</xref>&#x000a0;Several first- and second-generation ablation methods have been developed with differing benefits and disadvantages.&#x000a0;Hysterectomy is the only other surgical option available for women who experience heavy abnormal uterine bleeding.<xref ref-type="bibr" rid="article-21100.r5">[5]</xref>&#x000a0;However, endometrial ablation is an alternative therapeutic intervention with the benefits of decreased complication rates, pain, recovery, operating time, and uterine preservation compared to hysterectomy.<xref ref-type="bibr" rid="article-21100.r2">[2]</xref><xref ref-type="bibr" rid="article-21100.r6">[6]</xref></p>
      </sec>
      <sec id="article-21100.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Before performing endometrial ablation, evaluating the underlying cause of abnormal uterine bleeding is essential to ensure appropriate management. Abnormal uterine bleeding has a wide array of etiologies, which can be classified using the PALM-COEIN (polyp,&#x000a0;adenomyosis,&#x000a0;leiomyoma, malignancy;&#x000a0;coagulopathy,&#x000a0;ovulatory dysfunction,&#x000a0;endometrial,&#x000a0;iatrogenic, and&#x000a0;not yet classified) classification system developed by The International Federation of Gynecology and Obstetrics (FIGO) and has become a universally accepted terminology. These PALM-COEIN etiologies can be divided into structural groups, comprising polyps, adenomyosis, leiomyomas, or malignancies, and nonstructural groups, which include coagulopathies, ovulatory dysfunction, and conditions that are endometrial, iatrogenic, and not yet classified.<xref ref-type="bibr" rid="article-21100.r7">[7]</xref></p>
        <p>A transvaginal ultrasound, endometrial biopsy, saline infusion sonogram, or hysteroscopy may be used to determine structural abnormalities and provide information on the size and position of the uterus. Nonstructural causes of abnormal uterine bleeding can be due to endocrinopathies; underlying bleeding disorders, such as von Willebrand disease; or iatrogenic causes,&#x000a0;such as various contraceptive methods or medications, including anticoagulants.<xref ref-type="bibr" rid="article-21100.r7">[7]</xref>&#x000a0;Endometrial hyperplasia or malignancy is an underlying cause of abnormal uterine bleeding and should be excluded through endometrial histopathological analysis before performing an endometrial ablation. Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/20790">Abnormal Uterine Bleeding</ext-link>," for more information.</p>
        <p>The endometrial lining of the uterine cavity consists of 2 layers&#x02014;the functional layer and the basal layer. The functional layer performs physiological functions&#x000a0;such as proliferation, maintenance of pregnancy, and menstruation, whereas the basal layer is implicated in the regrowth of the functional layer.<xref ref-type="bibr" rid="article-21100.r8">[8]</xref><xref ref-type="bibr" rid="article-21100.r9">[9]</xref>&#x000a0;The various endometrial ablation techniques destroy the endometrial lining, removing the functional and basal layers.<xref ref-type="bibr" rid="article-21100.r10">[10]</xref>&#x000a0;By destroying these layers, endometrial regeneration is reduced or ceased, resulting in a decreased menstrual flow or complete amenorrhea.<xref ref-type="bibr" rid="article-21100.r2">[2]</xref><xref ref-type="bibr" rid="article-21100.r6">[6]</xref>&#x000a0;After endometrial ablation, necrosis, fibrosis, and inflammation are common histological findings of the uterine cavity.<xref ref-type="bibr" rid="article-21100.r11">[11]</xref></p>
      </sec>
      <sec id="article-21100.s4" sec-type="Indications">
        <title>Indications</title>
        <p>
<bold>Indicators for Patient Selection</bold>
</p>
        <p>Endometrial ablation is used to treat heavy abnormal uterine bleeding. Appropriate patient selection is crucial&#x000a0;when determining the most suitable approach&#x000a0;for managing abnormal uterine bleeding.<xref ref-type="bibr" rid="article-21100.r6">[6]</xref>&#x000a0;The ideal candidate for endometrial ablation is a patient with endometrium, as determined by the FIGO classification system, and does not desire definitive management through a hysterectomy.<xref ref-type="bibr" rid="article-21100.r12">[12]</xref><xref ref-type="bibr" rid="article-21100.r13">[13]</xref>&#x000a0;The following clinical factors indicate patients for whom&#x000a0;endometrial ablation is recommended:</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients of reproductive age with heavy menstrual bleeding that significantly impacts their quality of life due to a benign cause who have met their desired parity.</p>
          </list-item>
          <list-item>
            <p>Abnormal uterine bleeding without uterine abnormalities or with fibroids &#x0003c;3 cm in diameter.</p>
          </list-item>
          <list-item>
            <p>Abnormal uterine bleeding unrelated to hyperplasia or malignancy confirmed by endometrial biopsy.</p>
          </list-item>
          <list-item>
            <p>Abnormal uterine bleeding with failure or intolerance of medical management.</p>
          </list-item>
          <list-item>
            <p>Nonsurgical candidates due to surgical risks or preexisting comorbidities.</p>
          </list-item>
          <list-item>
            <p>Uterine cavity with a length &#x0003c;10 cm and a smooth contour, as determined by a preoperative transvaginal ultrasound or saline infusion sonogram.&#x000a0;<xref ref-type="bibr" rid="article-21100.r6">[6]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21100.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Contraindications to endometrial ablation include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pregnancy or desire for fertility preservation</p>
          </list-item>
          <list-item>
            <p>Endometrial hyperplasia or uterine malignancy</p>
          </list-item>
          <list-item>
            <p>Cervical cancer</p>
          </list-item>
          <list-item>
            <p>Active pelvic infection</p>
          </list-item>
          <list-item>
            <p>Retained intrauterine device</p>
          </list-item>
          <list-item>
            <p>History of transmyometrial uterine surgery or cesarean section</p>
          </list-item>
          <list-item>
            <p>Uterine anomalies, such as septate, bicornuate, or unicornuate uterus.<xref ref-type="bibr" rid="article-21100.r6">[6]</xref><xref ref-type="bibr" rid="article-21100.r14">[14]</xref><xref ref-type="bibr" rid="article-21100.r15">[15]</xref></p>
          </list-item>
        </list>
        <p>Relative contraindications include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Postmenopausal state</p>
          </list-item>
          <list-item>
            <p>Submucous leiomyomas</p>
          </list-item>
          <list-item>
            <p>Uterine cavity length &#x0003e;11 cm</p>
          </list-item>
          <list-item>
            <p>Severe myometrial thinning</p>
          </list-item>
          <list-item>
            <p>Severe uterine retroflection or anteflexion&#x000a0;<xref ref-type="bibr" rid="article-21100.r12">[12]</xref><xref ref-type="bibr" rid="article-21100.r11">[11]</xref><xref ref-type="bibr" rid="article-21100.r16">[16]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21100.s6" sec-type="Personnel">
        <title>Personnel</title>
        <p>The personnel required to perform an endometrial ablation typically include a gynecologist and an assistant. Endometrial ablation may be performed in the outpatient setting or an operating room.</p>
      </sec>
      <sec id="article-21100.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>Before performing an endometrial ablation, clinicians should discuss the patient's expectations of menstrual bleeding after the procedure. The goal is to decrease the amount of heavy menstrual bleeding, improving the patient's quality of life. Patients who desire amenorrhea may not be good candidates for endometrial ablation, as this outcome is not guaranteed with endometrial ablation.<xref ref-type="bibr" rid="article-21100.r6">[6]</xref>&#x000a0;The rates of amenorrhea range between&#x000a0;15%&#x000a0;and 72% 12 months after the procedure.<xref ref-type="bibr" rid="article-21100.r12">[12]</xref>&#x000a0;</p>
        <p>Counseling on future fertility and reliable contraception is also necessary because pregnancy after ablation carries high risks. Endometrial histology should be evaluated with endometrial biopsy. Uterine structure, including size, position, and cavity contour, should be assessed using various ultrasonographic modalities before the procedure.<xref ref-type="bibr" rid="article-21100.r5">[5]</xref><xref ref-type="bibr" rid="article-21100.r6">[6]</xref>&#x000a0;Endometrial ablation can be performed as an in-office procedure, which does not require general anesthesia, or as an outpatient procedure with general anesthesia; preoperative anesthesia evaluation and counseling should be tailored accordingly.<xref ref-type="bibr" rid="article-21100.r6">[6]</xref></p>
      </sec>
      <sec id="article-21100.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>The effectiveness of endometrial ablation is based on removing or destroying the basal layer of the endometrium, which is crucial in preventing regrowth of the uterine lining.&#x000a0;Historically, heavy menstrual bleeding was treated with either medications or a hysterectomy, both of which remain effective options. However, more recent treatments have shifted toward addressing the endometrium, the uterine lining that causes the bleeding. These newer methods either involve removing the endometrial lining through resection or destroying it with thermal energy in a procedure called ablation. These approaches have been shown to reduce or stop menstrual bleeding effectively.<xref ref-type="bibr" rid="article-21100.r10">[10]</xref>&#x000a0;A recent Cochran review found that first- and second-generation approaches are equally effective in treating heavy menstrual bleeding, with similar patient satisfaction rates. However, second-generation techniques showed decreased rates of some adverse outcomes, including&#x000a0;fluid overload, cervical lacerations, and hematometra.<xref ref-type="bibr" rid="article-21100.r10">[10]</xref></p>
        <p>Over the past few decades, endometrial ablation techniques have evolved significantly, providing less invasive alternatives to hysterectomy for treating heavy menstrual bleeding. These techniques were primarily divided into first- and second-generation endometrial ablation techniques based on the need to visualize the endometrium with hysteroscopy during the ablation procedure.<xref ref-type="bibr" rid="article-21100.r5">[5]</xref><xref ref-type="bibr" rid="article-21100.r6">[6]</xref>&#x000a0;Third-generation methods have further refined the ablation process, improving on second-generation approaches.<xref ref-type="bibr" rid="article-21100.r10">[10]</xref>&#x000a0;The specific procedures followed vary based on the ablation device used. Therefore, clinicians should follow manufacturers' guidelines when performing endometrial ablation procedures according to the device used.</p>
        <p>
<bold>First-Generation Techniques</bold>
</p>
        <p>Initially, first-generation techniques, such as laser photovaporization, rollerball ablation, and transcervical resection of the endometrium, were developed to&#x000a0;treat heavy menstrual bleeding. These methods required direct visualization of the uterine cavity with a hysteroscope. Despite their effectiveness, these methods had limitations, including the need for a skilled surgeon,&#x000a0;general anesthesia, and an operating room environment. In addition, these procedures were associated with a higher rate of complications, such as hemorrhage and uterine perforation. As these methods were complex and had associated patient morbidity, the expected reduction in hysterectomy rates was not fully realized.<xref ref-type="bibr" rid="article-21100.r5">[5]</xref></p>
        <p>
<bold>Second-Generation Techniques</bold>
</p>
        <p>In response to the deficiencies observed with the first-generation ablation methods, second-generation techniques were introduced, offering options that are easier to perform, equally effective, and associated with lower complication rates. Endometrial visualization is unnecessary with these newer methods, which include&#x000a0;thermal balloon, microwave, hydrothermal, bipolar radiofrequency, and cryotherapy techniques.<xref ref-type="bibr" rid="article-21100.r6">[6]</xref> These procedures can often be performed in outpatient settings, often under local anesthesia, and do not require the advanced hysteroscopic skills required for first-generation procedures. Second-generation techniques are associated with shorter procedure times and lower complication rates. These advancements have made endometrial ablation more accessible and cost-effective, leading to broader adoption and a significant impact on treatment options for women with heavy abnormal uterine bleeding.&#x000a0;Despite these advantages, current evidence does not definitively show that any second-generation method is superior to another, and there remains some uncertainty regarding the comparative safety and efficacy between first- and second-generation techniques.<xref ref-type="bibr" rid="article-21100.r10">[10]</xref></p>
        <p>
<bold>Third-Generation Techniques</bold>
</p>
        <p>The development of third-generation techniques, which improve upon earlier methods by enhancing safety and effectiveness, continues to refine the practice of endometrial ablation.&#x000a0;Third-generation methods offer improvements such as better heat distribution across the endometrial surface. For example, the Thermachoice III system, which replaces latex with silicone in the balloon and utilizes active fluid circulation,&#x000a0;provides more consistent heat application. These advancements aim to enhance the safety and effectiveness of the procedure.<xref ref-type="bibr" rid="article-21100.r10">[10]</xref>&#x000a0;However, the choice of technique often depends on the availability of specific equipment and the surgeon's experience. Despite the advancements, there remains a need for ongoing research to optimize outcomes and patient satisfaction with these techniques.<xref ref-type="bibr" rid="article-21100.r5">[5]</xref></p>
      </sec>
      <sec id="article-21100.s9" sec-type="Complications">
        <title>Complications</title>
        <p>First-generation endometrial ablation techniques have an estimated complication rate of 4.4%, whereas second- and third-generation techniques have a complication rate of approximately 1%.<xref ref-type="bibr" rid="article-21100.r10">[10]</xref>&#x000a0;Postoperative complications include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Perforation of pelvic organs</p>
          </list-item>
          <list-item>
            <p>Endometritis</p>
          </list-item>
          <list-item>
            <p>Myometritis</p>
          </list-item>
          <list-item>
            <p>Cervical lacerations or stenosis</p>
          </list-item>
          <list-item>
            <p>Pelvic sepsis</p>
          </list-item>
          <list-item>
            <p>Pelvic abscess</p>
          </list-item>
          <list-item>
            <p>Pelvic inflammatory disease</p>
          </list-item>
          <list-item>
            <p>Hematometra</p>
          </list-item>
          <list-item>
            <p>Uterine tamponade</p>
          </list-item>
          <list-item>
            <p>Blood transfusion</p>
          </list-item>
          <list-item>
            <p>Glycine toxicity</p>
          </list-item>
          <list-item>
            <p>Fluid overload</p>
          </list-item>
          <list-item>
            <p>Fluid deficit</p>
          </list-item>
          <list-item>
            <p>Bowel obstruction</p>
          </list-item>
          <list-item>
            <p>Urinary incontinence</p>
          </list-item>
          <list-item>
            <p>Pelvic pain&#x000a0;<xref ref-type="bibr" rid="article-21100.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Gas embolism</p>
          </list-item>
          <list-item>
            <p>Thermal injury</p>
          </list-item>
          <list-item>
            <p>Hemorrhage</p>
          </list-item>
          <list-item>
            <p>Intrauterine adhesions&#x000a0;<xref ref-type="bibr" rid="article-21100.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Vesicouterine fistula&#x000a0;<xref ref-type="bibr" rid="article-21100.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Pregnancy-related complications, such as premature birth, abnormal placentation, intrauterine growth restriction, and perinatal mortality</p>
          </list-item>
          <list-item>
            <p>Postablation tubal sterilization syndrome,&#x000a0;characterized by cyclic pelvic pain due to endometrial regrowth and distension of the uterine cornua with blocked fallopian tubes in patients who have undergone bilateral tubal ligation and endometrial ablation <xref ref-type="bibr" rid="article-21100.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Missed or delayed diagnosis of uterine carcinoma&#x000a0;<xref ref-type="bibr" rid="article-21100.r13">[13]</xref><xref ref-type="bibr" rid="article-21100.r11">[11]</xref><xref ref-type="bibr" rid="article-21100.r18">[18]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21100.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Traditionally, heavy menstrual bleeding was managed with medications or hysterectomy, which are still reliable treatments. However, newer options focus on targeting the endometrium, the uterine lining responsible for the bleeding. These newer treatments either remove the endometrium through resection or destroy it using thermal energy, a process known as ablation. These procedures have proven effective in reducing or eliminating menstrual bleeding.<xref ref-type="bibr" rid="article-21100.r10">[10]</xref></p>
        <p>Although&#x000a0;first-generation methods were more invasive and required a higher level of technical skill, the newer second- and third-generation techniques are easier to perform, less invasive, and have become increasingly popular alternatives to hysterectomy.&#x000a0;Overall, most patients have a satisfactory outcome in treating heavy menstrual bleeding. Both first- and second-generation methods have shown equal efficacy in outcomes.<xref ref-type="bibr" rid="article-21100.r6">[6]</xref><xref ref-type="bibr" rid="article-21100.r5">[5]</xref>&#x000a0;At 12 months after a nonresectoscopic endometrial ablation, 82% to 97% of patients showed decreased menstrual bleeding, and 85% to 98% were satisfied with their outcome.<xref ref-type="bibr" rid="article-21100.r12">[12]</xref></p>
        <p>As a result, the number of hysterectomies performed for heavy menstrual bleeding has significantly decreased. However, long-term studies indicate that some women may still require a hysterectomy following ablation, particularly in the years immediately after the procedure. Failure rates for endometrial ablations range from 5% to 16% within 5 years of undergoing the procedure, with patients requiring definitive hysterectomy to treat persistent pelvic pain or bleeding.<xref ref-type="bibr" rid="article-21100.r2">[2]</xref></p>
        <p>
<bold>Endometrial Ablation Compared to Nonsurgical Therapies</bold>
</p>
        <p>Among nonsurgical treatments, the levonorgestrel-releasing intrauterine system (LNG-IUS) is the most effective first-line option for reducing menstrual blood loss, offering a 71% to 95% reduction in blood loss. This effectiveness makes LNG-IUS comparable to hysterectomy when considering quality-adjusted life years. Antifibrinolytics, such as tranexamic acid, and long-cycle progestogens are also effective, but to a lesser extent, with reductions in menstrual blood loss ranging from 26% to 87%, depending on the specific treatment. Oral contraceptives also offer substantial reductions (35% to 69%), but continuous dosing of progestins, although effective, often has lower long-term patient satisfaction.<xref ref-type="bibr" rid="article-21100.r19">[19]</xref><xref ref-type="bibr" rid="article-21100.r20">[20]</xref><xref ref-type="bibr" rid="article-21100.r1">[1]</xref></p>
        <p>Endometrial ablation is highly effective in controlling bleeding.<xref ref-type="bibr" rid="article-21100.r1">[1]</xref> Studies show that endometrial resection provides better bleeding control at short-term follow-ups (for example, 4 months and 2 years)&#x000a0;compared to oral medications. However, this difference diminishes over extended periods (for example,&#x000a0;5 years). Unlike pharmacological treatments, which are reversible and preserve fertility, endometrial ablation is more invasive and typically considered when less invasive treatments fail or when fertility preservation is not a concern.<xref ref-type="bibr" rid="article-21100.r1">[1]</xref><xref ref-type="bibr" rid="article-21100.r19">[19]</xref></p>
        <p>Patient satisfaction with treatment outcomes varies between pharmacologic and surgical options. LNG-IUS is associated with high satisfaction rates, comparable to those observed with more invasive surgical options. In contrast, although suitable for some women, oral medications may not maintain high satisfaction over the long term. Endometrial ablation, particularly when compared to conservative surgical options, generally yields higher satisfaction rates in the short term (for example, at 1 year). However, over longer follow-ups, the difference in satisfaction between ablation and medical treatments such as LNG-IUS becomes less pronounced.<xref ref-type="bibr" rid="article-21100.r19">[19]</xref><xref ref-type="bibr" rid="article-21100.r20">[20]</xref></p>
        <p>The LNG-IUS and oral contraceptives have the advantage of being noninvasive and carrying fewer immediate risks compared to surgery. However, they may be associated with ongoing bleeding, spotting, or hormonal side effects. Although effective and generally well-tolerated, endometrial ablation carries risks associated with surgery. In addition, ablation is not suitable for women who wish to preserve fertility, as it typically results in permanent changes to the endometrial lining. Endometrial ablation offers a middle ground&#x02014;less invasive than hysterectomy but more permanent and effective compared to most pharmacologic options. For many women, particularly those who prefer to avoid surgery or preserve fertility, the LNG-IUS offers a highly effective and satisfactory long-term solution with a lower risk profile.<xref ref-type="bibr" rid="article-21100.r19">[19]</xref><xref ref-type="bibr" rid="article-21100.r20">[20]</xref><xref ref-type="bibr" rid="article-21100.r1">[1]</xref></p>
        <p>Although endometrial ablation provides a more definitive and immediate solution to heavy menstrual bleeding, pharmacological treatments, particularly the LNG-IUS, offer effective, less invasive alternatives that preserve fertility and have favorable safety profiles. Therefore, the choice between these options should be individualized, including the patient's desire for fertility preservation, tolerance for potential adverse effects, and preference for nonsurgical versus surgical interventions.<xref ref-type="bibr" rid="article-21100.r19">[19]</xref><xref ref-type="bibr" rid="article-21100.r20">[20]</xref><xref ref-type="bibr" rid="article-21100.r1">[1]</xref></p>
        <p>
<bold>Endometrial Ablation Compared to Hysterectomy</bold>
</p>
        <p>Historically, nearly half of all hysterectomies have been performed globally to treat abnormal uterine bleeding. Hysterectomy provides the definitive treatment for heavy uterine bleeding by eliminating menstruation and generally results in high patient satisfaction. However, hysterectomy is also a major surgery associated with significant physical risks, social implications, and higher costs. The associated risks and costs vary somewhat based on the hysterectomy method, such as abdominal and minimally invasive hysterectomies. Despite its effectiveness, many women seek less invasive alternatives even when informed that these alternatives may not guarantee complete success.<xref ref-type="bibr" rid="article-21100.r5">[5]</xref></p>
        <p>When&#x000a0;comparing minimally invasive hysterectomy and endometrial ablation, hysterectomy guarantees the cessation of menstruation but comes with significant risks and recovery time. In contrast, endometrial ablation offers a less invasive option with quicker recovery, although it may not always be as effective, and some women may eventually require further surgery. Both treatments have similar safety profiles regarding serious complications, but the choice between hysterectomy and endometrial ablation often depends on the patient's preference for a less invasive procedure versus the certainty of results.<xref ref-type="bibr" rid="article-21100.r5">[5]</xref></p>
      </sec>
      <sec id="article-21100.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Endometrial ablation requires a coordinated effort among a diverse team of healthcare professionals, each contributing specific skills and responsibilities to ensure patient-centered care, optimize outcomes, and enhance patient safety. Clinicians, who often lead the procedure, are responsible for assessing patients, determining candidacy for ablation, and performing the surgery with precision.&#x000a0;Advanced practitioners, such as nurse practitioners or clinician assistants, play a crucial role in preoperative and postoperative care. They assess patient readiness, provide education about the procedure, manage perioperative care, and monitor for complications.&#x000a0;Nurses are vital in both the preoperative and postoperative phases, providing patient education, managing anxiety, and monitoring vital signs. Nurses also play a crucial role in ensuring adherence to safety protocols, which are critical for preventing complications.</p>
        <p>Effective interprofessional communication and care coordination are crucial for the success of endometrial ablation. Clear documentation and standardized communication tools help ensure that all team members are on the same page, reducing the risk of errors and improving patient outcomes. Each professional must understand their role and how it fits into the larger care plan, working collaboratively to address any issues and ensuring that the patient receives comprehensive, patient-centered care. Through shared responsibilities and effective communication, the healthcare team can provide high-quality care tailored to the individual needs of the patient undergoing endometrial ablation.</p>
      </sec>
      <sec id="article-21100.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21100&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21100">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21100/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21100">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21100.s13">
        <title>References</title>
        <ref id="article-21100.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wouk</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Helton</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Abnormal Uterine Bleeding in Premenopausal Women.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Apr</month>
            <day>01</day>
            <volume>99</volume>
            <issue>7</issue>
            <fpage>435</fpage>
            <page-range>435-443</page-range>
            <pub-id pub-id-type="pmid">30932448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chodankar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Endometrial ablation for heavy menstrual bleeding.</article-title>
            <source>Womens Health (Lond)</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-52</page-range>
            <pub-id pub-id-type="pmid">26756668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suharwardy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chaturvedi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Fischer-Colbrie</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maratta</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Onnela</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Coull</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Hauser</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Baird</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Jukic</surname>
                <given-names>AMZ</given-names>
              </name>
              <name>
                <surname>Mahalingaiah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Curry</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women's Health Study.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>228</volume>
            <issue>2</issue>
            <fpage>213.e1</fpage>
            <page-range>213.e1-213.e22</page-range>
            <pub-id pub-id-type="pmid">36414993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benetti-Pinto</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Rosa-E-Silva</surname>
                <given-names>ACJS</given-names>
              </name>
              <name>
                <surname>Yela</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Soares J&#x000fa;nior</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Abnormal Uterine Bleeding.</article-title>
            <source>Rev Bras Ginecol Obstet</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>358</fpage>
            <page-range>358-368</page-range>
            <pub-id pub-id-type="pmid">28605821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bofill Rodriguez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lethaby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fergusson</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2021</year>
            <month>Feb</month>
            <day>23</day>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>CD000329</fpage>
            <pub-id pub-id-type="pmid">33619722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vitale</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Della Corte</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ciebiera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carugno</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Riemma</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lasmar</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Lasmar</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Kahramanoglu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Urman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Miku&#x00161;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Angelis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>T&#x000f6;r&#x000f6;k</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Angioni</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hysteroscopic Endometrial Ablation: From Indications to Instrumentation and Techniques-A Call to Action.</article-title>
            <source>Diagnostics (Basel)</source>
            <year>2023</year>
            <month>Jan</month>
            <day>17</day>
            <volume>13</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">36766443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munro</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Critchley</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Broder</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>IS</given-names>
              </name>
              <collab>FIGO Working Group on Menstrual Disorders</collab>
            </person-group>
            <article-title>FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>113</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-13</page-range>
            <pub-id pub-id-type="pmid">21345435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Critchley</surname>
                <given-names>HOD</given-names>
              </name>
              <name>
                <surname>Maybin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>ARW</given-names>
              </name>
            </person-group>
            <article-title>Physiology of the Endometrium and Regulation of Menstruation.</article-title>
            <source>Physiol Rev</source>
            <year>2020</year>
            <month>Jul</month>
            <day>01</day>
            <volume>100</volume>
            <issue>3</issue>
            <fpage>1149</fpage>
            <page-range>1149-1179</page-range>
            <pub-id pub-id-type="pmid">32031903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maybin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Critchley</surname>
                <given-names>HO</given-names>
              </name>
            </person-group>
            <article-title>Menstrual physiology: implications for endometrial pathology and beyond.</article-title>
            <source>Hum Reprod Update</source>
            <year>2015</year>
            <season>Nov-Dec</season>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>748</fpage>
            <page-range>748-61</page-range>
            <pub-id pub-id-type="pmid">26253932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bofill Rodriguez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lethaby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grigore</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hickey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farquhar</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Endometrial resection and ablation techniques for heavy menstrual bleeding.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Jan</month>
            <day>22</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD001501</fpage>
            <pub-id pub-id-type="pmid">30667064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drylewicz</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Endometrial ablation: normal appearance and complications.</article-title>
            <source>Abdom Radiol (NY)</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>43</volume>
            <issue>10</issue>
            <fpage>2774</fpage>
            <page-range>2774-2782</page-range>
            <pub-id pub-id-type="pmid">29541832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Famuyide</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Endometrial Ablation.</article-title>
            <source>J Minim Invasive Gynecol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>299</fpage>
            <page-range>299-307</page-range>
            <pub-id pub-id-type="pmid">28888699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munro</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Endometrial ablation.</article-title>
            <source>Best Pract Res Clin Obstet Gynaecol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>46</volume>
            <fpage>120</fpage>
            <page-range>120-139</page-range>
            <pub-id pub-id-type="pmid">29128205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Enzelsberger</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Oppelt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Enengl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Palme</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Trautner</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Perioperative complications in women undergoing thermal balloon endometrial ablation after one or more cesarean deliveries.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2024</year>
            <month>Aug</month>
            <volume>299</volume>
            <fpage>18</fpage>
            <page-range>18-21</page-range>
            <pub-id pub-id-type="pmid">38820689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharp</surname>
                <given-names>HT</given-names>
              </name>
            </person-group>
            <article-title>Assessment of new technology in the treatment of idiopathic menorrhagia and uterine leiomyomata.</article-title>
            <source>Obstet Gynecol</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>108</volume>
            <issue>4</issue>
            <fpage>990</fpage>
            <page-range>990-1003</page-range>
            <pub-id pub-id-type="pmid">17012464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Ibrahim</surname>
                <given-names>BLH</given-names>
              </name>
              <name>
                <surname>Husaynei</surname>
                <given-names>AJA</given-names>
              </name>
            </person-group>
            <article-title>Modified Thermal Balloon Endometrial Ablation for Treatment of Heavy Menstrual Bleeding.</article-title>
            <source>Gynecol Minim Invasive Ther</source>
            <year>2022</year>
            <season>Apr-Jun</season>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>100</fpage>
            <page-range>100-104</page-range>
            <pub-id pub-id-type="pmid">35746908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greer Polite</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>DeAgostino-Kelly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marchand</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Combination of Laparoscopic Salpingectomy and Endometrial Ablation: A Potentially Underused Procedure.</article-title>
            <source>J Gynecol Surg</source>
            <year>2021</year>
            <month>Feb</month>
            <day>01</day>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-91</page-range>
            <pub-id pub-id-type="pmid">35153453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Louie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Siedhoff</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>The case against endometrial ablation for treatment of heavy menstrual bleeding.</article-title>
            <source>Curr Opin Obstet Gynecol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-292</page-range>
            <pub-id pub-id-type="pmid">29708902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marjoribanks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lethaby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farquhar</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Surgery versus medical therapy for heavy menstrual bleeding.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Jan</month>
            <day>29</day>
            <volume>2016</volume>
            <issue>1</issue>
            <fpage>CD003855</fpage>
            <pub-id pub-id-type="pmid">26820670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21100.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bofill Rodriguez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dias</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lethaby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lensen</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Wise</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Farquhar</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2022</year>
            <month>May</month>
            <day>31</day>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>CD013180</fpage>
            <pub-id pub-id-type="pmid">35638592</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
